nexstim

Nexstim adds Chronic Neuropathic Pain Therapy to its clinical indication pipeline with co-operation agreement with the Walton Center

on 16/12/2014 16:53
Nexstim announces a co-operation agreement with The Walton Centre
Read more

Nexstim Plc successfully completes its Initial Public Offering - subscriptions reach € 15.3 million with final offer price of € 6.35 per share

on 04/11/2014 15:37

Nexstim Launches Next Generation NBS 5 System

on 18/09/2014 10:58
New device to be showcased at two international congresses.
Read more

Nexstim progresses its navigated brain stimulation technology in stroke and demonstrates improved outcomes in brain tumor surgery

on 28/08/2014 10:21
Study on track and sites selected and initiated in multicenter clinical trial on the therapeutic effects of NBT® for stroke rehabilitation.
Read more

Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome

on 24/02/2014 11:23
Neurosurgeons advocate for increased use of presurgical brain mapping
Read more